Ligand · 276
276 · 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide
276, 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide (C21 H15 Cl F3 N5 O2, 461.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- 276
- Formula
- C21 H15 Cl F3 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
276 in 2 structures; the first of them:
- 2QU5 · Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor · 276 A501 · binds LEU840, VAL848, ALA866, LYS868, GLU885, ILE888, LEU889, ILE892 and 16 more
- 2QU5 · Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor · 276 A501 · binds LEU840, VAL848, ALA866, LYS868, GLU885, ILE888, LEU889, ILE892 and 16 more
Residues it binds most
ILE 2, LEU 2, VAL 2, CYS 2, GLU 2, LYS 2, PHE 2, ALA 2, ASP 2, GLY 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.